Genic제닉
123330 · KOSDAQ · ₩123330 · 제닉
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩3,490
vs the current price (₩16,580)
- Enterprise value
- ₩30B
- Equity value
- ₩28B
- WACC
- 7.3%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 79% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩16,580, the model needs an operating margin of 6.0% every year (it uses 2.1%).
- Margins ranged from −14.3% to 19.1% over the last 5 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- 53% of the last 12 months' net profit came from outside operations (stakes in other companies, interest, one-offs). The model adds those stakes at book value but doesn't project that income.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- —
- Base
- ₩3,490
- −78.9%
- Bull
- ₩14,157
- −14.6%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (2.1%).
Revenue growth
- 25%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (35.5% a year, annual reports), fading to 3% by year 5.
- 19.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (35.5% a year, annual reports), fading to 3% by year 5.
- 14%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (35.5% a year, annual reports), fading to 3% by year 5.
- 8.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (35.5% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (35.5% a year, annual reports), fading to 3% by year 5.
Business
- 2.1%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 3.6%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 3.2%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 12.8%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.08%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-29.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta -0.25, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.58%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩114B
- Net debt (borrowings and leases − cash and deposits)
- ₩1.9B
- Shares
- 7,968,680
- Share price
- ₩16,580
- Market cap
- ₩132B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩28B | ₩50B | ₩78B | ₩143B | ₩171B | ₩195B | ₩211B | ₩217B |
| Growth | −10.7% | 77.8% | 56.7% | 25.0% | 19.5% | 14.0% | 8.5% | 3.0% |
| EBIT | −₩4B | ₩6B | ₩15B | ₩3B | ₩3.6B | ₩4.1B | ₩4.4B | ₩4.6B |
| EBIT margin | −14.3% | 12.1% | 19.1% | 2.1% | 2.1% | 2.1% | 2.1% | 2.1% |
| After-tax EBIT | −₩2.9B | ₩4.4B | ₩11B | ₩2.2B | ₩2.6B | ₩3B | ₩3.2B | ₩3.3B |
| + Depreciation | ₩1.6B | ₩1.5B | ₩1.6B | ₩5.1B | ₩6.1B | ₩7B | ₩7.6B | ₩7.8B |
| − Capital spending | ₩841M | ₩1.7B | ₩2.7B | ₩4.6B | ₩5.5B | ₩6.2B | ₩6.8B | ₩7B |
| − Working capital | −₩5.7B | ₩6.2B | −₩2.4B | ₩3.7B | ₩3.6B | ₩3.1B | ₩2.1B | ₩811M |
| Free cash flow | ₩3.5B | −₩2B | ₩12B | −₩911M | −₩284M | ₩682M | ₩1.9B | ₩3.4B |
| Discount factor | — | — | — | 0.932 | 0.868 | 0.809 | 0.753 | 0.702 |
| Present value | — | — | — | −₩849M | −₩246M | ₩552M | ₩1.5B | ₩2.4B |
Terminal value ₩38B, worth ₩26B today: 89% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩7,001 a share)Now 2.37× | ₩13,9231.99× | ₩17,4432.49× | ₩77,09211.0× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | ₩4,124 | ₩4,282 | ₩4,475 | ₩4,714 | ₩5,021 |
| 6.8% | ₩3,692 | ₩3,802 | ₩3,931 | ₩4,088 | ₩4,282 |
| 7.3% | ₩3,329 | ₩3,404 | ₩3,490 | ₩3,592 | ₩3,714 |
| 7.8% | ₩3,020 | ₩3,070 | ₩3,125 | ₩3,189 | ₩3,264 |
| 8.3% | ₩2,754 | ₩2,785 | ₩2,818 | ₩2,856 | ₩2,898 |
Now (TTM)
- Market cap
- ₩132B
- Enterprise value
- ₩131B
- P/E
- 4.5×
- P/B
- 2.4×
- P/S
- 1.2×
- EV/EBITDA
- 6.2×
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩16,520 | ₩22,950 | ₩3,600 | ₩4,400 | ₩6,180 |
| Market cap | ₩132B | ₩183B | ₩29B | ₩35B | ₩49B |
| P/E | 7.0× | 24.2× | — | — | — |
| P/B | 3.2× | 8.3× | 2.5× | 2.2× | 2.6× |
| P/S | 1.7× | 3.7× | 1.0× | 1.1× | 1.3× |
| EV/EBITDA | 7.3× | 24.8× | — | — | — |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Genic | 4.5× | 2.4× | 1.2× | 6.2× | 0.0% |
| LG Chem | — | 0.5× | 0.3× | — | 0.8% |
| Hanwha Solutions | — | 0.6× | 0.4× | — | 0.0% |
| Hanwha | 6.3× | 0.4× | 0.1× | — | 1.4% |
| SKC | — | 2.1× | 2.0× | — | 0.0% |
| KCC | 0.9× | 0.3× | 0.5× | 8.9× | 0.0% |
| Kumho Petro Chemical | 5.3× | 0.4× | 0.4× | — | 1.6% |
| Similar companies (median) | 5.3× | 0.4× | 0.4× | 8.9× | 0.4% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Genic / 제닉 / 123330 / KRX:123330
Source: KRX statistical information